DEUTSCHE BANK AG\
BankPosition in FDMT — 4D Molecular Therapeutics, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in FDMT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$9,455,528
+$2,863,639 QoQ
Shares Held
710,942
+0.4% QoQ
Ownership
0.985%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 158 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 28%
Shared 0%
None 72%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,189,780,209 across 296 Biotechnology names. FDMT ranks #46 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in FDMT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,455,528 | 710,942 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $6,591,889 | 708,044 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $5,281,552 | 704,207 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,721,546 | 543,331 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $841,943 | 226,939 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $762,786 | 236,157 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $1,347,120 | 241,853 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $8,676,505 | 802,637 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $2,609,875 | 124,339 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $3,882,459 | 121,860 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $9,866,478 | 486,993 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $198,193 | 15,569 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $12,218,084 | 676,153 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,379,789 | 80,267 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,665,061 | 74,969 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $589,492 | 73,320 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $92,785 | 13,293 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $234,646 | 15,519 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $379,188 | 17,283 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $454,740 | 16,861 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $256,234 | 10,641 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $421,262 | 9,711 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||